Search

Gregory J. Tryder

Supervisory Patent Examiner (ID: 19032, Phone: (571)270-7365 , Office: P/2617 )

Most Active Art Unit
2629
Art Unit(s)
2600, 2617, 2692, 2626, 2629
Total Applications
245
Issued Applications
113
Pending Applications
0
Abandoned Applications
133

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6568405 [patent_doc_number] => 20100234374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (HDAC) Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/086812 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22750 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234374.pdf [firstpage_image] =>[orig_patent_app_number] => 12086812 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/086812
Heterocycle substituted ketone derivatives as histone deacetylase (HDAC) inhibitors Dec 20, 2006 Issued
Array ( [id] => 14236 [patent_doc_number] => 07803949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Process for preparation of water-soluble azole prodrugs' [patent_app_type] => utility [patent_app_number] => 12/097244 [patent_app_country] => US [patent_app_date] => 2006-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 9567 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803949.pdf [firstpage_image] =>[orig_patent_app_number] => 12097244 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/097244
Process for preparation of water-soluble azole prodrugs Dec 19, 2006 Issued
Array ( [id] => 5080495 [patent_doc_number] => 20070123719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Synthesis of cannabinoids' [patent_app_type] => utility [patent_app_number] => 11/642377 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5411 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20070123719.pdf [firstpage_image] =>[orig_patent_app_number] => 11642377 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/642377
Synthesis of cannabinoids Dec 18, 2006 Abandoned
Array ( [id] => 5041260 [patent_doc_number] => 20070093542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Process for the preparation of valsartan and intermediates thereof' [patent_app_type] => utility [patent_app_number] => 11/639502 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9810 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093542.pdf [firstpage_image] =>[orig_patent_app_number] => 11639502 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/639502
Process for the preparation of valsartan and intermediates thereof Dec 13, 2006 Abandoned
Array ( [id] => 4575273 [patent_doc_number] => 07855227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-21 [patent_title] => '2-phenylethylamino derivatives as calcium and/or sodium channel modulators' [patent_app_type] => utility [patent_app_number] => 12/158491 [patent_app_country] => US [patent_app_date] => 2006-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 33347 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/855/07855227.pdf [firstpage_image] =>[orig_patent_app_number] => 12158491 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/158491
2-phenylethylamino derivatives as calcium and/or sodium channel modulators Nov 28, 2006 Issued
Array ( [id] => 13826 [patent_doc_number] => 07807702 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Substituted thiophene carboxylic amide glucagon receptor antagonists, preparation and therapeutic uses' [patent_app_type] => utility [patent_app_number] => 12/094406 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14550 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807702.pdf [firstpage_image] =>[orig_patent_app_number] => 12094406 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/094406
Substituted thiophene carboxylic amide glucagon receptor antagonists, preparation and therapeutic uses Nov 20, 2006 Issued
Array ( [id] => 5447222 [patent_doc_number] => 20090048448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'SALTS OF CYNNAMIDE COMPOUND OR SOLVATES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/093929 [patent_app_country] => US [patent_app_date] => 2006-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15470 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048448.pdf [firstpage_image] =>[orig_patent_app_number] => 12093929 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/093929
SALTS OF CYNNAMIDE COMPOUND OR SOLVATES THEREOF Nov 16, 2006 Abandoned
Array ( [id] => 4904763 [patent_doc_number] => 20080114177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'METHOD FOR PREPARING FLUORINATED BENZOTRIAZOLE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/560078 [patent_app_country] => US [patent_app_date] => 2006-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6629 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20080114177.pdf [firstpage_image] =>[orig_patent_app_number] => 11560078 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/560078
METHOD FOR PREPARING FLUORINATED BENZOTRIAZOLE COMPOUNDS Nov 14, 2006 Abandoned
Array ( [id] => 4580005 [patent_doc_number] => 07834038 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Methods for preparing nonpeptidic oligomers from amino acids' [patent_app_type] => utility [patent_app_number] => 11/595383 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 58 [patent_no_of_words] => 9849 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/834/07834038.pdf [firstpage_image] =>[orig_patent_app_number] => 11595383 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/595383
Methods for preparing nonpeptidic oligomers from amino acids Nov 8, 2006 Issued
Array ( [id] => 4972000 [patent_doc_number] => 20070112003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => '3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use of thereof' [patent_app_type] => utility [patent_app_number] => 11/593030 [patent_app_country] => US [patent_app_date] => 2006-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26143 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20070112003.pdf [firstpage_image] =>[orig_patent_app_number] => 11593030 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/593030
3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof Nov 5, 2006 Issued
Array ( [id] => 380137 [patent_doc_number] => 07309712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-18 [patent_title] => '1H-pyrazoles useful in therapy' [patent_app_type] => utility [patent_app_number] => 11/592574 [patent_app_country] => US [patent_app_date] => 2006-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22864 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/309/07309712.pdf [firstpage_image] =>[orig_patent_app_number] => 11592574 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/592574
1H-pyrazoles useful in therapy Nov 2, 2006 Issued
Array ( [id] => 4779442 [patent_doc_number] => 20080287440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Novel Antifungal Triazole Derivatives' [patent_app_type] => utility [patent_app_number] => 12/092156 [patent_app_country] => US [patent_app_date] => 2006-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13702 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287440.pdf [firstpage_image] =>[orig_patent_app_number] => 12092156 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/092156
Antifungal triazole derivatives Oct 30, 2006 Issued
Array ( [id] => 928631 [patent_doc_number] => 07314941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-01 [patent_title] => 'Synthesis of phosphono-substituted porphyrin compounds for attachment to metal oxide surfaces' [patent_app_type] => utility [patent_app_number] => 11/553542 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20349 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/314/07314941.pdf [firstpage_image] =>[orig_patent_app_number] => 11553542 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/553542
Synthesis of phosphono-substituted porphyrin compounds for attachment to metal oxide surfaces Oct 26, 2006 Issued
Array ( [id] => 580322 [patent_doc_number] => 07449266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Perfluoropolyether benzotriazole compounds' [patent_app_type] => utility [patent_app_number] => 11/553853 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8519 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449266.pdf [firstpage_image] =>[orig_patent_app_number] => 11553853 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/553853
Perfluoropolyether benzotriazole compounds Oct 26, 2006 Issued
Array ( [id] => 4486111 [patent_doc_number] => 07902400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'Amide compounds and their use' [patent_app_type] => utility [patent_app_number] => 12/084130 [patent_app_country] => US [patent_app_date] => 2006-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34062 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902400.pdf [firstpage_image] =>[orig_patent_app_number] => 12084130 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/084130
Amide compounds and their use Oct 19, 2006 Issued
Array ( [id] => 5041258 [patent_doc_number] => 20070093540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => ' PROCESS FOR THE PREPARATION OF ANGIOTENSIN II ANTAGONISTIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/551094 [patent_app_country] => US [patent_app_date] => 2006-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3353 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093540.pdf [firstpage_image] =>[orig_patent_app_number] => 11551094 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/551094
PROCESS FOR THE PREPARATION OF ANGIOTENSIN II ANTAGONISTIC COMPOUNDS Oct 18, 2006 Abandoned
Array ( [id] => 8164828 [patent_doc_number] => 08173704 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Difluorophenol derivatives and their use' [patent_app_type] => utility [patent_app_number] => 12/083509 [patent_app_country] => US [patent_app_date] => 2006-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24108 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173704.pdf [firstpage_image] =>[orig_patent_app_number] => 12083509 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/083509
Difluorophenol derivatives and their use Oct 8, 2006 Issued
Array ( [id] => 5546699 [patent_doc_number] => 20090156576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases' [patent_app_type] => utility [patent_app_number] => 11/995928 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 102045 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156576.pdf [firstpage_image] =>[orig_patent_app_number] => 11995928 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/995928
Azetidines as MEK inhibitors for the treatment of proliferative diseases Oct 4, 2006 Issued
Array ( [id] => 5417031 [patent_doc_number] => 20090042918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Pyridopyrimidinone Inhibitors of PIM-1 and/or PIM-3' [patent_app_type] => utility [patent_app_number] => 12/088474 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27149 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042918.pdf [firstpage_image] =>[orig_patent_app_number] => 12088474 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/088474
Pyridopyrimidinone inhibitors of PIM-1 and/or PIM-3 Oct 4, 2006 Issued
Array ( [id] => 5120932 [patent_doc_number] => 20070142647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues' [patent_app_type] => utility [patent_app_number] => 11/540519 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8482 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142647.pdf [firstpage_image] =>[orig_patent_app_number] => 11540519 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/540519
Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues Oct 1, 2006 Abandoned
Menu